Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Cancer news

Show

From To
Screen all HIV-positive MSM for pre-cancerous anal cell changes, say Dutch investigators

Younger age and shorter duration of viral suppression are risk factors for the development of high-grade pre-cancerous anal lesions in HIV-positive men who have sex

Published
15 November 2017
By
Michael Carter
Nivolumab improves outcomes in liver cancer study

Nivolumab (Opdivo), a PD-1 checkpoint inhibitor that helps the immune system fight cancer, was associated with a decrease in tumour size or disease stabilisation in people with hepatocellular

Published
14 November 2017
By
Liz Highleyman
For cancer patients with HIV, immunotherapy appears safe

Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials

Published
08 November 2017
From
Fred Hutch
European AIDS Clinical Society strengthens HPV vaccination advice

The European AIDS Clinical Society (EACS) has recommended HPV (human papillomavirus) vaccination for everyone living with HIV aged under 26 and all men who have

Published
08 November 2017
By
Keith Alcorn
ART reduces HPV, cervical cancer in women with HIV

Women with HIV on ART had a lower prevalence of high-risk HPV infection, high-grade cervical lesions and invasive cervical cancer than women who were not receiving ART, according to results of a recent meta-analysis.

Published
06 November 2017
From
Healio
European HIV Guidelines Make Special HPV Recommendations for Gay Men

Gay and bisexual men with HIV should get vaccinated for human papillomavirus (HPV) up until age 40, according to updated guidelines from the European AIDS Clinical Society (EACS), released this week at the 16th European AIDS Conference. And others with HIV should be vaccinated until age 26, the guidelines state.

Published
30 October 2017
From
Medscape (requires free registration)
HIV virus fighter linked to cancer mutations

University of Saskatchewan researchers have found the onset of breast, lung and other cancers may be connected to malfunctions of the immune system as it combats specific viruses such as HIV.

Published
26 October 2017
From
University of Saskatchewan
Deaths Rates of Liver Cirrhosis Exceed Those of 5 Major Cancers

A new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that liver cirrhosis mortality is greater than that of five major cancers, implying the development of appropriate interventions to treat or prevent liver cirrhosis must be prioritized.

Published
23 October 2017
From
AASLD
FDA approves a game-changing treatment for non-Hodgkin lymphoma

The Food and Drug Administration on Wednesday approved a promising new treatment for a particularly deadly form of cancer, bringing hope to desperate patients while rekindling a global conversation about the escalating cost of new therapies.

Published
19 October 2017
From
STAT
Gay Men May Be Able to Self-Check for Anal Cancer

A recent study found that self- and partner exams were a fairly reliable way of identifying anal abnormalities that may be signs of cancer.

Published
04 October 2017
From
Poz
← First12345...46Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.